Close Menu

NEW YORK (GenomeWeb) – Flagship Biosciences today said it is collaborating with Advanced Cell Diagnostics for the use of its RNAscope technology. 

Flagship said it is using ACD's technology to support ongoing CLIA-based clinical trials of its clients. Steve Potts, vice president of sales and marketing for Westminster, Colo.-based Flagship, told GenomeWeb in an email that his firm is using RNAscope and customizing and optimizing the technology for use in trials with "several large" undisclosed pharmaceutical clients. 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

In PLOS this week: preconception carrier screening program results, comparative genomics-based analysis of Elizabethkingia meningoseptica, and more.

Canadian regulators are beginning to share information from new drug studies, Undark reports.

In a column at the Dallas Morning News, the Stanley Medical Research Institute's E. Fuller Torrey says the Human Genome Project hasn't delivered on promised results.

Researchers explore a possible genetic cause for some cases of sudden infant death syndrome, KOMO News reports.